Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Activation Of TAK1 By MYD88 L265P Drives Malignant B Cell Growth In Non-Hodgkin Lymphomas

Stephen M Ansell, M.D., Ph.D., Lucy S. Hodge, PharmD, Ph.D., Frank Secreto, Michelle Manske, Esteban Braggio, Ph.D., TAmmy Price-Troska, Steven Ziesmer, Ying Li, Sarah Johnson, Steven Hart, Jean-Pierre Kocher, George Vasmatzis, PhD, Asher Chanan-Khan, MD, Morie Abraham Gertz, MD, Rafael Fonseca, MD, Ahmet Dogan, MD, PhD, James R Cerhan, MD, PhD, Anne J. Novak, PhD

Blood (2013) 122 (21): 245.

https://doi.org/10.1182/blood.V122.21.245.245

Published: 2013

Journal Articles

A Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)

Angela Dispenzieri, MD, Morie Abraham Gertz, MD, Martha Q Lacy, MD, Kristina Laumann, Betsy R. LaPlant, Shaji Kumar, MD, Francis K Buadi, M.D., Suzanne R. Hayman, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Stephen M Ansell, MD, Dennis A. Gastineau, MD, David James Inwards, MD, Ivana N. Micallef, MD, Luis F. Porrata, MD, Patrick B. Johnston, Mark R. Litzow, MD, Thomas E. Witzig, MD

Blood (2011) 118 (21): 3095.

https://doi.org/10.1182/blood.V118.21.3095.3095

Published: 2011

Journal Articles

IgD Amyloidosis: An Unrecognized Entity

Morie Abraham Gertz, MD, Francis K Buadi, M.D., Suzanne R Hayman, MD, David Dingli, M.D., Ph.D., Angela Dispenzieri, Philip R. Greipp, MD, Shaji Kumar, Martha Q Lacy, MD, John A Lust, MD, PhD, Nelson Leung, MD, S. Vincent Rajkumar, MD, Stephen J. Russell, MD, PhD, Steven R Zeldenrust, MD, PhD, Joseph R. Mikhael, MD, Vivek Roy, MD, FACP, Robert A Kyle, MD

Blood (2011) 118 (21): 5079.

https://doi.org/10.1182/blood.V118.21.5079.5079

Published: 2011

Journal Articles

Trend towards Improved Day 100 and 2-Year Survival After SCT for AL Amyloidosis: Outcomes Before and After 2006

Morie Abraham Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, M.D., Shaji Kumar, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Nelson Leung, MD, William J Hogan, MBBCh, Suzanne R. Hayman, MD

Blood (2010) 116 (21): 3554.

https://doi.org/10.1182/blood.V116.21.3554.3554

Published: 2010

Journal Articles

Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization.

Morie Abraham Gertz, MD, Dennis Gastineau, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Shaji Kumar, MD, David Dingli, M.D., Ph.D., Nelson Leung, MD, Robert Wolf, PharmD, RPh, William J Hogan, MBBCh, Francis Buadi, MD

Blood (2010) 116 (21): 3469.

https://doi.org/10.1182/blood.V116.21.3469.3469

Published: 2010

Journal Articles

A Multidisciplinary Quality Initiative for Stem Cell Transplantation in Multiple Myeloma: Outpatient Transplant with Low Therapy Related Mortality

Morie Abraham Gertz, MD, Stephen M Ansell, David Dingli, Angela Dispenzieri, Francis K. Buadi, Michelle A Elliott, Dennis A Gastineau, Suzanne R Hayman, William J Hogan, David J Inwards, Patrick B Johnston, Shaji Kumar, Martha Q Lacy, Nelson Leung, Ivana NM Micallef, Luis F Porrata, Barbara A Schafer, Robert C Wolf, Mark R Litzow

Blood (2008) 112 (11): 4440.

https://doi.org/10.1182/blood.V112.11.4440.4440

Published: 2008

Journal Articles

Clinical Outcome of Immunoglobulin Light Chain Amyloidosis Affecting the Kidney

Morie Abraham Gertz, MD, Nelson Leung, Martha Q Lacy, Angela Dispenzieri, Steven R Zeldenrust, Suzanne R Hayman, Francis K. Buadi, David Dingli, Philip R. Greipp, Shaji Kumar, John A Lust, S. Vincent Rajkumar, Stephen J Russell, Thomas E. Witzig

Blood (2008) 112 (11): 5124.

https://doi.org/10.1182/blood.V112.11.5124.5124

Published: 2008

Journal Articles

Comparison of High-Dose Cyclophosphamide and Growth Factor with Growth Factor Alone for Mobilization of Stem Cells for Transplantation in Patients with Multiple Myeloma.

Morie Abraham Gertz, MD, Shaji Kumar, Martha Lacy, Angela Dispenzieri, Suzanne Hayman, Francis Buadi, David Dingli, Dennis Gastineau, Jeffery Winters, Mark Litzow

Blood (2008) 112 (11): 2301.

https://doi.org/10.1182/blood.V112.11.2301.2301

Published: 2008

Journal Articles

Relationship of Stem Cell Transplant and Risk of Atrial Fibrillation in Multiple Myeloma: A Case-Control Study.

Morie Abraham Gertz, MD, Kaniz Fatema, MBBS, Ivana N. Micallef, MD, Amy D. Eisinger, Marion E. Barnes, Stephen S. Cha, Teresa S. Tsang, MD

Blood (2007) 110 (11): 3001.

https://doi.org/10.1182/blood.V110.11.3001.3001

Published: 2007

Journal Articles

Should Troponin Level Be an Exclusion Criterion for Stem Cell Transplantation in Primary Amyloidosis?.

Morie Abraham Gertz, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Shaji K. Kumar, MD, Francis Buadi, MD, Nelson Leung, MD, Mark R. Litzow

Blood (2007) 110 (11): 3003.

https://doi.org/10.1182/blood.V110.11.3003.3003

Published: 2007

Journal Articles

The Serum M-Spike and Transplant Outcome in Patients with Multiple Myeloma.

David Dingli, MD, PhD, Jorge M. Pacheco, PhD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Shaji Kumar, MD, Martha Lacy, MD, Dennis A. Gastineau, MD, Morie Abraham Gertz, MD

Blood (2006) 108 (11): 5441.

https://doi.org/10.1182/blood.V108.11.5441.5441

Published: 2006

Journal Articles

Single Versus Multiple Transplants for Multiple Myeloma: Insights from In Vivo and In Silico Studies.

David Dingli, MD, PhD, Jorge M. Pacheco, PhD, Morie Abraham Gertz, MD

Blood (2006) 108 (11): 5452.

https://doi.org/10.1182/blood.V108.11.5452.5452

Published: 2006

Journal Articles

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

Wee-Joo Chng, MD, Angela Baker, PhD, Travis Henry, PhD, Tammy Price-Troska, Scott Van Wier, Tae-Hoon Chung, PhD, Kim Henderson, Gregory Ahmann, Martha Lacy, MD, Angela Dispenzieri, MD, Morie Abraham Gertz, MD, Philip Greipp, MD, Peter Leif Bergsagel, MD, John Carpten, PhD, Rafael Fonseca, MD

Blood (2006) 108 (11): 113.

https://doi.org/10.1182/blood.V108.11.113.113

Published: 2006

Journal Articles

Transplantation without Growth Factor. Engraftment Kinetics Following Stem Cell Transplantation for Primary Systemic Amyloidosis.

Morie Abraham Gertz, MD, Martha Q. Lacy, M.D., Angela Dispenzieri, M.D., Suzanne R. Hayman, M.D., Shaji K. Kumar, M.D., Dennis A. Gastineau, M.D.

Blood (2006) 108 (11): 2956.

https://doi.org/10.1182/blood.V108.11.2956.2956

Published: 2006

Journal Articles

Risk Factors of Treatment Related Mortality during Autologous Stem Cell Transplant in Patients with Light Chain Associated Amyloidosis (AL).

Nelson Leung, MD, Angela Dispenzieri, MD, Martha Q. Lacy, MD, Suzanne R. Hayman, MD, Shaji Kumar, MD, Morie Abraham Gertz, MD

Blood (2006) 108 (11): 3082.

https://doi.org/10.1182/blood.V108.11.3082.3082

Published: 2006

Journal Articles

Sequential Heart and Autologous Stem Cell Transplantation for AL Amyloidosis.

Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Shaji Kumar, MD, Robert Kyle, MD, S. Vincent Rajkumar, MD, Brooks S. Edwards, MD, Richard J. Rodeheffer, MD, Frantz P. Robert, MD, Sudhir S. Kushwaha, MD, Alfedo L. Clavell, MD, Joseph A. Dearani, MD, Thoralf M. Sundt, MD, Richard C. Daly, MD, Christopher G. A. McGregor, MD, Dennis A. Gastineau, MD, Morie Abraham Gertz, MD

Blood (2006) 108 (11): 3092.

https://doi.org/10.1182/blood.V108.11.3092.3092

Published: 2006

Journal Articles

Extent of Hematologic Response Is Important in Determining Outcome in Transplanted Patients with Primary Amyloidosis AL. Importance of Achieving CR.

Morie Abraham Gertz, MD, Martha Q. Lacy, M.D., Angela Dispenzieri, M.D., Suzanne R. Hayman, M.D., Shaji K. Kumar, M.D., Dennis A. Gastineau, M.D.

Blood (2006) 108 (11): 611.

https://doi.org/10.1182/blood.V108.11.611.611

Published: 2006

Journal Articles

A Phase II Study of Alemtuzumab in the Treatment of Plasma Cell Disorders.

Lijo Simpson, MBBS, Shaji Kumar, MBBS, Jacob Allred, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Steven Zeldenrust, MD, S. Vincent Rajkumar, MBBS, John A. Lust, MD, Philip R. Greipp, MD, Morie Abraham Gertz, MD, Thomas E. Witzig, MD

Blood (2006) 108 (11): 5126.

https://doi.org/10.1182/blood.V108.11.5126.5126

Published: 2006

Journal Articles

Response to Rituximab in Type II Cryoglobulinemia.

Alan H. Bryce, MD, Angela Dispenzieri, MD, Robert A. Kyle, MD, Martha Lacy, MD, S. Vincent Rajkumar, MD, David James Inwards, MD, Christopher Yasenchak, MD, Shaji Kumar, MD, Morie Abraham Gertz, MD

Blood (2005) 106 (11): 3499.

https://doi.org/10.1182/blood.V106.11.3499.3499

Published: 2005

Journal Articles

Role of Second Stem Cell Transplant in Patients with Amyloidosis Who Are Refractory or Relapsing.

Morie Abraham Gertz, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Shaji K. Kumar, MD, Stephen M. Ansell, MD, Michelle A. Elliott, MD, Dennis A. Gastineau, MD, David J. Inwards, MD, Patrick B. Johnston, MD, Ivana N. Micallef, MD, Luis F. Porrata, MD, Mark R. Litzow, MD

Blood (2005) 106 (11): 5469.

https://doi.org/10.1182/blood.V106.11.5469.5469

Published: 2005

NARROW

Activation Of TAK1 By MYD88 L265P Drives Malignant B Cell Growth In Non-Hodgkin Lymphomas

A Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)

IgD Amyloidosis: An Unrecognized Entity

Trend towards Improved Day 100 and 2-Year Survival After SCT for AL Amyloidosis: Outcomes Before and After 2006

Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization.

A Multidisciplinary Quality Initiative for Stem Cell Transplantation in Multiple Myeloma: Outpatient Transplant with Low Therapy Related Mortality

Clinical Outcome of Immunoglobulin Light Chain Amyloidosis Affecting the Kidney

Comparison of High-Dose Cyclophosphamide and Growth Factor with Growth Factor Alone for Mobilization of Stem Cells for Transplantation in Patients with Multiple Myeloma.

Relationship of Stem Cell Transplant and Risk of Atrial Fibrillation in Multiple Myeloma: A Case-Control Study.

Should Troponin Level Be an Exclusion Criterion for Stem Cell Transplantation in Primary Amyloidosis?.

The Serum M-Spike and Transplant Outcome in Patients with Multiple Myeloma.

Single Versus Multiple Transplants for Multiple Myeloma: Insights from In Vivo and In Silico Studies.

Combined High Resolution Array Comparative Genomic Hybridization and Gene Expression Profiling Reveal Rb1 Haploinsufficiency as a Possibile Tumorigenic Mechanism in Myeloma.

Transplantation without Growth Factor. Engraftment Kinetics Following Stem Cell Transplantation for Primary Systemic Amyloidosis.

Risk Factors of Treatment Related Mortality during Autologous Stem Cell Transplant in Patients with Light Chain Associated Amyloidosis (AL).

Sequential Heart and Autologous Stem Cell Transplantation for AL Amyloidosis.

Extent of Hematologic Response Is Important in Determining Outcome in Transplanted Patients with Primary Amyloidosis AL. Importance of Achieving CR.

A Phase II Study of Alemtuzumab in the Treatment of Plasma Cell Disorders.

Response to Rituximab in Type II Cryoglobulinemia.

Role of Second Stem Cell Transplant in Patients with Amyloidosis Who Are Refractory or Relapsing.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only